Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Other Non-Current Liabilities (2018 - 2025)

Entera Bio has reported Other Non-Current Liabilities over the past 4 years, most recently at $393000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $393000.0, compared with a TTM value of $393000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $393000.0, changed N/A over the prior year.
  • Other Non-Current Liabilities came in at $393000.0 for Q4 2025, down from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $393000.0 in Q4 2025 to a low of $393000.0 in Q4 2025.